Get the Stockscreener App
0.24
1.72%
-0.0042
Bionexus Gene Lab Corp stock is traded at $0.24, with a volume of 69,885.
It is down -1.72% in the last 24 hours and down -36.00% over the past month.
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
See More
Previous Close:
$0.2442
Open:
$0.239
24h Volume:
69,885
Relative Volume:
0.20
Market Cap:
$4.28M
Revenue:
$10.34M
Net Income/Loss:
$-3.09M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-736.20K
1W Performance:
-20.00%
1M Performance:
-36.00%
6M Performance:
-53.85%
1Y Performance:
+0.00%
1-Day Range:
$0.2315
$0.24
1-Week Range:
$0.2313
$0.31
52-Week Range:
$0.2313
$3.39
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
Name
Bionexus Gene Lab Corp
Sector
Industry
Phone
1-307-241-6898
Address
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
1.14 | 201.51M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
21.49 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.14 | 315.71M | 2.07B | -1.42B | -1.37B | -0.1344 |
|
SHMD
Schmid Group N V
|
2.32 | 99.04M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
4.72 | 60.87M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.155 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp Stock (BGLC) Latest News
BGLC stock touches 52-week low at $0.28 amid sharp annual decline By Investing.com - Investing.com South Africa
BGLC stock touches 52-week low at $0.28 amid sharp annual decline - Investing.com Nigeria
BioNexus Gene Lab Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
BioNexus Gene Lab Corp (BGLC) Quarterly 10-Q Report - Quartzy
BioNexus Gene Lab stock hits 52-week low at $0.32 By Investing.com - Investing.com Canada
BioNexus Gene Lab stock hits 52-week low at $0.32 - Investing.com
BioNexus Gene Lab faces Nasdaq delisting over price rule - Investing.com India
BioNexus Gene Lab faces Nasdaq delisting over price rule By Investing.com - Investing.com Nigeria
BioNexus Gene Lab Faces Delisting and Leadership Changes - TipRanks
BioNexus Gene Lab announces board resignations By Investing.com - Investing.com Australia
BioNexus Gene Lab announces board resignations - Investing.com India
BioNexus Gene Lab faces vote impact from alleged proxy issues By Investing.com - Investing.com Australia
BioNexus Gene Lab faces vote impact from alleged proxy issues - Investing.com India
bionexus gene lab corp Earnings dates - RTTNews
BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update - Defense World
BioNexus Gene Lab Corporation announces entry into Biogas - GlobeNewswire
BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd. - StockTitan
BioNexus Gene Lab Corp (BGLC) Stock: A Year of Market Fluctuations - The InvestChronicle
There is no way BioNexus Gene Lab Corp (BGLC) can keep these numbers up - SETE News
In the Green: BioNexus Gene Lab Corp (BGLC) Closes at 0.39, Up/Down 8.36 from Previous Day - The Dwinnex
BioNexus partners with Vitarray for gene detection - Investing.com
BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd. - Marketscreener.com
BioNexus Gene Lab Corp (BGLC) requires closer examination - US Post News
Bionexus Gene Lab in MOU with Shenzhen Rongguang Group for cancer screening - TipRanks
BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions - GlobeNewswire
Closing Figures: BioNexus Gene Lab Corp (BGLC)’s Positive Finish at 0.36, Up 2.48 - The Dwinnex
BioNexus Gene Lab Corp (BGLC) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
BioNexus subsidiary invests in color paste production By Investing.com - Investing.com India
Bionexus Gene Lab’s Chemrex invests RM 2M to begin color paste production - TipRanks
BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production - StockTitan
BioNexus Gene Lab Corp revises stockholder quorum requirement - Investing.com India
How did BioNexus Gene Lab Corp (BGLC) fare last session? - US Post News
An analyst sees good growth prospects for BioNexus Gene Lab Corp (BGLC) - SETE News
BioNexus Receives Government Backing for Healthcare Tech - TipRanks
BioNexus and MyCIF invest in Malaysian healthcare tech By Investing.com - Investing.com Australia
BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd - Yahoo Finance UK
BioNexus Gene Lab Corp (BGLC)’s Market Momentum: Closing Strong at 0.44, Up 4.05 - The Dwinnex
BioNexus Gene Lab’s Strategic Investment in AI Healthcare - TipRanks
BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd - Marketscreener.com
Ascension Innovation raises RM1.7m funding - The Malaysian Reserve
BioNexus Gene Lab Second Quarter 2024 Earnings: US$0.005 loss per share (vs US$0.018 loss in 2Q 2023) - Yahoo Finance
Ascension Innovation Becomes First ECF Issuer To Secure MyCIF Environmental & Social Impact Fund - BusinessToday
Reviewing Exagen (NASDAQ:XGN) and BioNexus Gene Lab (NASDAQ:BGLC) - Defense World
Bionexus Gene Lab Corp Stock (BGLC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
0.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):